Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: Activation of STAT-6 and JNK is inhibited by chlorogenic acid

International Immunopharmacology

Volumn 10, Issue 10, 2010, Pages 1242-1248

  Kim, Hye Rin ^a   Lee, Dong Min ^a   Lee, Seung Hun ^a   Seong, Ah Reum ^a   Gin, Dah Won ^a   Hwang, Ju Ae ^a   Park, Joo Hung ^a  

^a Changwon National University   (South Korea)

Author keywords

Asthma; C germ line transcription; Chlorogenic acid; IgE; JNK; Ovalbumin; STAT 6

Indexed keywords

CHLOROGENIC ACID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G3; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG INHIBITION; GERM LINE; LOEFFLER PNEUMONIA; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; TH2 CELL; THERAPY EFFECT; TREATMENT RESPONSE; WESTERN BLOTTING;

ANIMALS; ARTEMISIA; ASTHMA; CHLOROGENIC ACID; CYTOKINES; HYPERSENSITIVITY; IMMUNOGLOBULIN E; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY EOSINOPHILIA; STAT6 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 77957255077     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.07.005     Document Type: Article

References (50)

1. Walker C., Kaegi M., Braun P., Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991, 88:935-942.
2. Elwood W., Barnes P.J., Chung K.F. Airway hyperresponsiveness is associated with inflammatory cell infiltration in allergic brown-Norway rats. Int Arch Allergy Immunol 1992, 99:91-97.
3. Lundgren J.D., Shelhamer J.H. Pathogenesis of airway mucus hypersecretion. J Allergy Clin Immunol 1990, 85:399-404.
4. Elias J.A. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000, 161:s168-s171.
5. Brusselle G.G., Kips J.C., Tavernier J.H., van der Heyden J.G., Cuvelier C.A., Pauwels R.A., et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994, 24:73-80.
6. Coyle A.J., Le Gros G., Bertrand C., Tsuyuki S., Heusser C.H., Kopf M., et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995, 13:54-59.
7. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988, 167:1737-1742.
8. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., Vadas M.A. Rcombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988, 167:219-224.
9. Broide D.H., Stachnick G., Castaneda D., Nayar J., Sriramarao P. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75- and TNF receptor p55-deficient mice. Am J Respir Cell Mol Biol 2001, 24:304-311.
10. 2 activation. J Allergy Clin Immunol 2005, 116:537-543.
11. H2 cytokine productiom in an asthma model in mice. J Allergy Clin Immunol 2007, 120:48-55.
12. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988, 140:1022-1027.
13. Iwamoto I., Nakajima H., Endo H., Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993, 167:219-224.
14. Iwamoto I., Kumano K., Kasai M., Kurasawa K., Nakao A. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am J Respir Crit Care Med 1996, 154:1257-1260.
15. Barnes P.J. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998, 102:531-538.
16. Szefler S.J., Leung D.Y. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J 1997, 10:1640-1647.
17. Jang S.I., Kim Y.J., Kim H.J., Lee J.C., Kim H.Y., Kim Y.C., et al. Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kB activation in U937 cells. Life Sci 2006, 78:2937-2943.
18. Huang W., Zhang J., Moore D.D. A traditional Chinese medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 2004, 113:137-143.
19. Lee J.A., Sung H.N., Jeon C.H., Gill B.C., Oh G.S., Youn H.J., et al. A carbohydrate fraction, AIP1 from Artemisia iwayomogi suppresses pulmonary eosinophilia and Th2-type cytokine production in an ovalbumin-induced allergic asthma. Down regulation of TNF-α expression in the lung. Int Immunopharmacol 2008, 8:117-125.
20. - scavenging activity. Phytother Res 2004, 18:1-7.
21. Ahn H., Kim J.Y., Kim Y.K., Ryu J.H. Inhibitors of inducible nitric oxide synthase expression from Artemisia iwayomogi. Arch Pharm Res 2003, 26:301-305.
22. Ricciardolo F.L.M. cNOS-iNOS paradigm and arginase in asthma. Trends Pharmacol Sci 2003, 24:560-561.
23. Sud'ina G.F., Mirzoeva O.K., Pushkareva M.A., Korshunova G.A., Sumbatyan N.V., Varfolomeev S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993, 329:21-24.
24. Nardini M., Scaccini C., Packer L., Virgili F. In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim Biophys Acta 2000, 1474:219-225.
25. Natarajan K., Singh S., Burke T.R., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996, 93:9090-9095.
26. Marquez N., Sancho R., Macho A., Calzado M.A., Fiebich B.L., Muñoz E. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J Pharmacol Exp Ther 2004, 308:993-1001.
27. Yoshioka K., Deng T., Cavigelli M., Karin M. Antitumor promotion by phenolic antioxidant: inhibition of AP-1 activity through induction of Fra expression. Proc Natl Acad Sci USA 1995, 92:4972-4976.
28. Boyer J., Liu R.H. Apple phytochemicals and their health benefits. Nutr J 2004, 3:5-19.
29. King A., Young G. Characteristics and occurrence of phenolic phytochemicals. J Am Diet Assoc 1999, 99:213-218.
30. Kono Y., Kashine S., Yoneyama T., Sakamoto Y., Matsui Y., Shibata H. Iron chelation by chlorogenic acid as a natural antioxidant. Biosci Biotechnol Biochem 1998, 62:22-27.
31. Wang G.F., Shi L.P., Ren Y.D., Liu Q.F., Liu H.F., Zhang R.J., et al. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res 2009, 83:186-190.
32. Kasai H., Fukada S., Yamaizumi Z., Sugie S., Morie H. Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat carcinogenesis model. Food Chem Toxicol 2000, 38:467-471.
33. Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Immunopharmacol Immunotoxicol 2002, 24:113-119.
34. Yin Y., Xie M., Wu H., Jiang M., Zheng J., Wei Q. Interaction of calcineurin with its activator, chlorogenic acid revealed by spectroscopic methods. Biochimie 2009, 91:820-825.
35. Kang N.J., Lee K.W., Shin B.J., Jung S.K., Hwang M.K., Bode A.M., et al. Caffeic acid, a phenolic phytochemiacl in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 2009, 30:321-330.
36. Wang S.H., Chen C.S., Huang S.H., Yu S.H., Lai Z.Y., Huang S.T., et al. Hydrophilic ester-bearing chlorogenic acid binds to a novel domain to inhibit xanthine oxidase. Planta Med 2009, 75:1237-1240.
37. Snapper C.M., Finkelman F.D., Paul W.E. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med 1988, 167:183-196.
38. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Biol Chem 1988, 140:1022-1027.
39. Geha R.S., Jabara H.H., Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nature Rev Immunol 2003, 3:721-732.
40. Jabara H.H., Geha R.S. Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J Allergy Clin Immunol 2005, 115:856-863.
41. Basaki Y., Ikizawa K., Kajiwara K., Yanagihara Y. CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cepsilin transcription in a human B cell line. Arch Biochem Biophys 2002, 405:199-204.
42. Shan J., Fu J., Zhao Z., Kong X., Huang H., Luo L., et al. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxigenase-2 expression in RAW264.7 cells through suppressing NF-ΚB and JNK/AP-1 activation. Int Immunopharmacol 2009, 9:1042-1048.
43. Chen S.S., Gong J., Liu F.T., Mohammed U. Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000, 100:471-480.
44. Stavnezer J. Antibody class switching. Adv Immunol 1996, 61:79-146.
45. Purkerson J.M., Isakson P.C. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE. J Exp Med 1992, 175:973-982.
46. Yuan D., Vitteta E. Structual studies of cell surface and secreted IgG in LPS-stimulated murine B cells. Mol Immunol 1983, 20:367-375.
47. Woods R.K., Walters E.H., Raven J., Wolfe R., Ireland P., Thien F., et al. Food and nutrient intakes and asthma risk in young adults. Am J Clin Nutr 2003, 78:414-421.
48. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., et al. lavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002, 76:560-568.
49. Folwarczna J., Zych M., Burczyk J., Trzeciak H., Trzeciak H.I. Effects of natural phenolic acids on the skeletal system of ovariectomized rats. Planta Med 2009, 75:1567-1572.
50. Zych M., Folwarczna J., Pytlik M., Sliwinski L., Golden M.A., Burczyk J., et al. Administration of caffeic acid worsened bone mechanical properties in female rats. Planta Med 2010, 76:407-411.